TERTIARY AMINES FOR USE IN THE TREATMENT OF CARDIAC DISORDERS
申请人:Universitetet I Oslo
公开号:US20150133510A1
公开(公告)日:2015-05-14
The present invention relates to tertiary amines of formula (I) for use in therapy, particularly for use in treating cardiovascular disorders. The compounds have been found to regulate phospholamban phosphorylation by interfering with the A-kinase anchor protein 18delta (AKAP185) binding to the PKA substrate phospholamban. The compounds share a tri(alkylaryl/alkylheteroaryl)amine structure.
[EN] TERTIARY AMINES FOR USE IN THE TREATMENT OF CARDIAC DISORDERS<br/>[FR] AMINES TERTIAIRES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT DE TROUBLES CARDIAQUES
申请人:UNI I OSLO
公开号:WO2013171332A3
公开(公告)日:2014-04-17
US9556111B2
申请人:——
公开号:US9556111B2
公开(公告)日:2017-01-31
US9951033B2
申请人:——
公开号:US9951033B2
公开(公告)日:2018-04-24
Flow synthesis of organic azides and the multistep synthesis of imines and amines using a new monolithic triphenylphosphine reagent
作者:Catherine J. Smith、Christopher D. Smith、Nikzad Nikbin、Steven V. Ley、Ian R. Baxendale
DOI:10.1039/c0ob00813c
日期:——
Here we describe general flow processes for the synthesis of alkyl and aryl azides, and the development of a new monolithic triphenylphosphine reagent, which provides a convenient format for the use of this versatile reagent in flow. The utility of these new tools was demonstrated by their application to a flow Staudinger aza-Wittig reaction sequence. Finally, a multistep aza-Wittig, reduction and